EULAR PsA recommendations update emphasizes safety, nonmusculoskeletal manifestationsJune 9, 2023Rheumatology
Gout linked to smaller brain volume, higher likelihood of neurodegenerative diseasesJune 7, 2023RheumatologyNeurologyAlzheimer's & Cognition
Cell activity in psoriasis may predict disease severity and provide clues to comorbiditiesJune 7, 2023DermatologyRheumatology
Early axial spondyloarthritis diagnosis in referred patients remains stable in mostJune 6, 2023Rheumatology
Investigational uricase-based gout drug meets primary endpoints in phase 3 trialsJune 6, 2023Rheumatology
EULAR systemic sclerosis recommendations now include immunosuppressantsJune 5, 2023DermatologyRheumatologyRare Diseases
URAT1 inhibitor shows ‘substantial’ uric acid reduction in phase 2 gout trialJune 5, 2023Rheumatology
Encouraging telitacicept results reported in phase 3 for lupus, phase 2 for Sjögren’sJune 2, 2023Rheumatology
Scientists discover variants, therapy for disabling pansclerotic morpheaJune 2, 2023Rare DiseasesDermatologyRheumatologyMixed Topics
Enthesitis, arthritis, tenosynovitis linked to dupilumab use for atopic dermatitisJune 1, 2023DermatologyRheumatologyAsthmaGastroenterology
Two biologics show no difference in axial spondyloarthritis radiographic progression over 2 yearsJune 1, 2023Rheumatology
